BTG Pactual Asset Management US’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
VCM
VPM
BTG Pactual Asset Management US's MDT Position: Q1 2026 in Review
BTG Pactual Asset Management US sold out of Medtronic (MDT) in Q1 2026, closing a stake of 3,027 shares — an estimated $291K sold.
BTG Pactual Asset Management US first reported a position in MDT in Q4 2025 and held it in 1 quarter. The position peaked at $291K in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- BTG Pactual Asset Management US reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
- BTG Pactual Asset Management US sold 3,027 Medtronic shares in Q1 2026, an estimated $291K.
- BTG Pactual Asset Management US first reported a position in Medtronic in Q4 2025 and held it in 1 quarter.
- BTG Pactual Asset Management US's Medtronic position peaked at $291K in Q4 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on BTG Pactual Asset Management US's 13F filing for Q1 2026, filed 14 May 2026.